Application of triple negative breast cancer patient-derived organoid and xenograft model for drug screening

被引：0
|
作者：
Ryu, Seungyeon [1 ]
Kim, Hoe Suk [2 ]
Kim, Jung Eun [3 ]
Yoon, So-Hyun [1 ]
Lee, Sangeun [2 ]
Baek, Moonjou [2 ]
Lee, Han-Byoel [4 ]
Lee, Dong Woo [3 ]
Ku, Bosung [3 ]
Han, Wonshik [4 ]
机构：
[1] Seoul Natl Univ, Grad Sch, Integrated Major Innovat Med Sci, Seoul, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[3] Med & Bio Decis, Suwon, South Korea
[4] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6039
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
    Park, Hyung Seok
    Lee, Jeong Dong
    Kim, Jee Ye
    Park, Seho
    Kim, Joo Heung
    Han, Hyun Ju
    Choi, Yeon A.
    Choi, Ae Ran
    Sohn, Joo Hyuk
    Kim, Seung Il
    [J]. PLOS ONE, 2019, 14 (12):
  • [42] Pharmacologic profiling of patient-derived xenograft models of primary treatment-naive triple-negative breast cancer
    Powell, Reid T.
    Redwood, Abena
    Liu, Xuan
    Guo, Lei
    Cai, Shirong
    Zhou, Xinhui
    Tu, Yizheng
    Zhang, Xiaomei
    Qi, Yuan
    Jiang, Yan
    Echeverria, Gloria
    Feng, Ningping
    Ma, XiaoYan
    Giuliani, Virginia
    Marszalek, Joseph R.
    Heffernan, Timothy P.
    Vellano, Christopher P.
    White, Jason B.
    Stephan, Clifford
    Davies, Peter J.
    Moulder, Stacy
    Symmans, W. Fraser
    Chang, Jeffrey T.
    Piwnica-Worms, Helen
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] Antitumoral synergy of iron chelators and chemotherapies in triple-negative breast cancer cell lines and patient-derived xenograft
    Tury, Sandrine
    Vacher, Sophie
    Becette, Veronique
    Assayag, Franck
    Chateau-Joubert, Sophie
    Servely, Jean-Luc
    Marangoni, Elisabetta
    Bieche, Ivan
    Callens, Celine
    [J]. CANCER RESEARCH, 2017, 77
  • [44] Establishment of Metastatic Breast Cancer Patient-Derived Xenograft
    Abou Hussein, Bassem
    Al Ozaibi, Labib
    Al Mazrouei, Alya
    Badri, Faisal
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E81 - E81
  • [45] Patient-Derived Xenograft Models in Breast Cancer Research
    Na, Deukchae
    Moon, Hyeong-Gon
    [J]. TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 283 - 301
  • [46] Patient-derived cell line, xenograft and organoid models in lung cancer therapy
    Huo, Ku-Geng
    D'Arcangelo, Elisa
    Tsao, Ming-Sound
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2214 - 2232
  • [47] Miniaturizing patient-derived organoid screening assays for predictive drug testing
    Abouleila, Yasmine
    Verkerk, Roel
    Doorn, Mayke
    Voskuilen, Timo
    Harada, Gakuro
    Watanabe, Masahiko
    Smabers, Lidwien
    Kyan, Hideaki
    Kumagai, Takahiko
    Hikichi, Yuichi
    Overmeer, Rene
    Roodhart, Jeanine
    Matsuno, Kiyotaka
    Verissimo, Carla
    Boj, Sylvia
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [48] Metabolic Response to Everolimus in Patient-Derived Triple Negative Breast Cancer Xenografts
    Euceda, Leslie R.
    Hill, Deborah K.
    Stokke, Endre
    Hatem, Rana
    El Botty, Rania
    Bieche, Ivan
    Marangoni, Elisabetta
    Bathen, Tone F.
    Moestue, Siver A.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2017, 16 (05) : 1868 - 1879
  • [49] Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research
    Tsutomu Kawaguchi
    Barbara A. Foster
    Jessica Young
    Kazuaki Takabe
    [J]. Journal of Mammary Gland Biology and Neoplasia, 2017, 22 : 131 - 139
  • [50] Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
    Tan, Dengxu
    An, Jiaze
    Gong, Miaomiao
    Wang, Huihui
    Li, Han
    Meng, Han
    Zhang, Caiqin
    Zhao, Yong
    Ge, Xu
    Shi, Changhong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345